A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
Global gene expression analysis was performed on pre-treatment biopsies from patients with squamous cell carcinoma of the head and neck (SCCHN) to discover biomarkers that can predict outcome of radiation based therapy.